While proper hydration is important, excessive water intake (more than 3-4 litres daily) without electrolyte replacement could potentially cause electrolyte imbalances
In 2026, two oral GLP-1 receptor agonists are positioned to reshape this market: **oral semaglutide** (approved for weight loss in December 2025) and **orforglipron** (Eli Lilly's non-peptide candidate expected to receive an FDA decision by mid-to-late 2026)
July 16, 2026 GLP-1s Are Working Now Medicine Needs to Measure What Matters This article from MedCity News covers: GLP-1s Are Working Now Medicine Needs to Measure What Matters
By partnering with our expert team at the Michael Horn Plastic Surgery & Lumire Medspa, you can expect the following benefits: Significant weight loss, especially when combined with a healthy diet and exercise routine
Not registered in Medicaid or other state or federal health programs
Only three randomized controlled trials have been conducted so far but with short term follow-up periods
